Form 4 for IDXX Idexx Laboratories
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001567619-22-004789 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-16 | 2022-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +838 | 2,619 | +47% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $505.53 | -253 | 2,504 | -9% | -$127.9K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | — | -838 | 2,858 | -23% | — |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | — | +6,806 | 5,917 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 483 | $0.00 | 2,401.99 | D | — | — | (F1) Includes a total of 40.9949 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021. |
| 2 | Common | Common Stock | 2022-02-14 | F | D | 253 | $505.53 | 2,503.99 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-14 | M | A | 138 | $0.00 | 2,756.99 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-14 | M | A | 217 | $0.00 | 2,618.99 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 138 | — | 2,503 | D | — · — to — | 138 Common Stock | (F8) Not applicable. (F7) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 6 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 217 | — | 2,641 | D | — · — to — | 217 Common Stock | (F8) Not applicable. (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 7 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 483 | — | 2,858 | D | — · — to — | 483 Common Stock | (F8) Not applicable. (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 8 | Derivative | Restricted Stock Unit | 2022-02-14 | A | A | 692 | — | 3,341 | D | — · — to — | 692 Common Stock | (F8) Not applicable. (F4) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| 9 | Derivative | Incentive Stock Option (right-to-buy) | 2022-02-14 | A | A | 197 | — | 197 | D | $505.53 · — to 2032-02-13 | 197 Common Stock | (F8) Not applicable. (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. |
| 10 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2022-02-14 | A | A | 5,917 | — | 5,917 | D | $505.53 · — to 2032-02-13 | 5,917 Common Stock | (F8) Not applicable. (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. |